Home/Filings/3/0001553350-21-000044
3//SEC Filing

Cavalry Fund I LP 3

Accession 0001553350-21-000044

CIK 0001000683other

Filed

Jan 14, 7:00 PM ET

Accepted

Jan 15, 8:41 AM ET

Size

5.7 KB

Accession

0001553350-21-000044

Insider Transaction Report

Form 3
Period: 2020-12-14
Holdings
  • Common Stock

    1,250,000
  • Warrants

    Exercise: $1.25From: 2020-12-15Exp: 2023-12-15Common Stock (625,000 underlying)
Footnotes (1)
  • [F1]Pursuant to that certain Securities Purchase Agreement, dated December 14, 2020, between Blonder Tongue Laboratories, Inc. (the "Company") and Cavalry Fund I LP (the "Reporting Person"), the Reporting Person purchased 1,250,000 shares of the Company's common stock ("Common Stock") and warrants to purchase 625,000 shares of Common Stock at an exercise price of $1.25 per share (the "Warrants"). The Warrants are exercisable at any time from December 15, 2020 until December 15, 2023 at 5:00 p.m., New York City time, subject to a beneficial ownership limitation of 4.99% of the Company's issued and outstanding Common Stock.

Documents

1 file

Issuer

BLONDER TONGUE LABORATORIES INC

CIK 0001000683

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001677197

Filing Metadata

Form type
3
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 8:41 AM ET
Size
5.7 KB